Aquapharm's R&D is focused on developing new and commercially valuable products derived from marine microbiology.

The company's discovery process combines microbiology, screening and natural product chemistry to provide a robust platform for the discovery of novel compounds and bioactives for future use as novel anti-inflammatory, tissue-protective and antibiotic drugs and functional ingredients for the personal care and food and beverage markets.

All of Aquapharm's research and development is conducted to the highest scientific quality standards. Extracts are screened in vitro against cell-based assays as an effective and rapid method of identifying novel compounds.

SeaRch™

Aquapharm uses a range of induction technologies and culturing methodologies, including its proprietary screening technology, SeaRch™, to gain access to the full spectrum of bio-active compounds that the marine microbes in its collection can produce. These technologiesunlock the evolutionary legacy of these microbes' chemical arsenals revealing a wider array of metabolites of interest than has traditionally been possible.